Hongyin Sun
Guangzhou, 510080, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Corrigendum to "BRD4 inhibitor suppresses melanoma metastasis via the SPINK6 EGFR-EphA2 pathway" [Pharmacol. Res. 187 (2023) 106609].
Journal: Pharmacological research
Published: July 14, 2026
Deep learning model enables the discovery of a novel BET inhibitor YD-851.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: May 07, 2025
Discovery of WD-890: A novel allosteric TYK2 inhibitor for the treatment of multiple autoimmune diseases.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: June 09, 2023
Combined BET and MEK Inhibition synergistically suppresses melanoma by targeting YAP1.
Journal: Theranostics
Published: April 19, 2023
Single-Cell Profiling Reveals Sustained Immune Infiltration, Surveillance, and Tumor Heterogeneity in Infiltrative Basal Cell Carcinoma.
Journal: The Journal of investigative dermatology
Published: July 31, 2022
BRD4 inhibitor suppresses melanoma metastasis via the SPINK6/EGFR-EphA2 pathway.
Journal: Pharmacological research
Published: July 06, 2022
Editorial: Epigenetic Regulation and Tumor Immunotherapy.
Journal: Frontiers in oncology
Published: March 10, 2022
eEF2K promotes PD-L1 stabilization through inactivating GSK3β in melanoma.
Journal: Journal for immunotherapy of cancer
Published: March 03, 2022
CECR2 drives breast cancer metastasis by promoting NF-κB signaling and macrophage-mediated immune suppression.
Journal: Science translational medicine
Published: February 02, 2022
Potent BRD4 inhibitor suppresses cancer cell-macrophage interaction.
Journal: Nature communications
Published: June 06, 2018
Showing 1-11 of 11
Last Updated: 09/26/2026